Corporate Update and Investor Presentation – November 2021
LexaGene hosts regular corporate updates and investor presentations to keep you apprised of our progress commercializing the MiQLab molecular diagnostics platform. Here’s the audio of our November 3rd, 2021 presentation, with a downloadable slide deck for future reference: Presentation Audio Corporate Presentation Slide Deck Download Slide Deck
Virtual Investor Conference Webcast
Listen to CEO and Founder, Dr. Jack Regan tell the LexaGene story to prospective investors, October 7, 2021:
Lytham Partners Fall Conference Audio
Couldn’t make it to the Lytham Partners Fall Conference this year? Here’s audio of our presentation, no registration required:
Bringing Automated PCR Testing for Pathogens Inside the Hospital
Dr. Manoj Nair recently spoke at the Southwest Veterinary Symposium. His presentation provided insight into how LexaGene’s MiQLab, a fully automated system for accurate and reliable qPCR testing at point-of-care, supports rapid, evidence-based treatment decisions and prevents the spread of antimicrobial resistance in a veterinary hospital setting. Download Presentation Automated Pathogen Testing for Veterinary Hospitals…
In-Clinic PCR Testing Presentation
Watch Dr. Jack Regan’s In-Clinic PCR Testing for Pathogen ID & Antibiotic Resistance Testing Presentation from the 2021 Western Veterinary Conference in Las Vegas: Learn about our fully automated system for accurate and reliable qPCR testing at point-of-care to enable evidence-based treatment decisions.
Rapid Detection of UTI Pathogens at the Veterinary Clinic with MiQLab’s Bacterial and AMR Test
Rapid and accurate identification of disease-causing bacterial pathogens in companion animals can aid veterinarians in administering effective treatment plans. Traditional culture and sensitivity testing can give valuable insight regarding these pathogens, however, there is still a long turnaround time associated with results. To tackle this problem, LexaGene performed a study to assess the use of…
Lytham Partners Investor Conference – Summer 2021
On Monday, June 14, Dr. Regan spoke at the Lytham Partners Summer 2021 Investor Conference about the company’s growing value as a biotechnology investment. LexaGene management will also participate in one-on-one meetings throughout the event, which runs from June 14-16. To arrange a meeting, please contact a Lytham Partners representative or register on their website.
LexaGene’s MiQLab is the first automated, open-access system for pathogen detection, allowing users to test for multiple pathogens on-site and return results rapidly.